Document ID: chunk:federal_register_of_legislation:F2023L00444:schedule:1
Version: federal_register_of_legislation:F2023L00444
Segment Type: schedule
Provision Reference: sch 1
Character Range: 2104–3779

Schedule 1— Description of quality assurance activity
1 Name of activity
The name of the quality assurance activity is the Australasian Vascular Audit (AVA).
2 Description of activity
This quality assurance activity aims to capture all private and public vascular surgery procedures performed in Australia and New Zealand including both open and endovascular procedures. Data collected by the activity is analysed annually to assess in-hospital performance across five main areas of vascular surgery:
1. Aortic aneurysm, aortic dissection, and aortoiliac occlusive disease
2. Lower limb peripheral arterial disease
3. Stroke prevention from carotid atherosclerosis
4. Vascular access for haemodialysis in renal failure
5. Venous disease including varicose veins
The activity will be conducted by the Australian and New Zealand Society for Vascular Surgery (ANZSVS). The quality assurance activity described in this declaration applies only to health services provided in Australia.
The objectives of the AVA are to:
 1. maintain the highest achievable standard of vascular surgery in Australasia;
 2. allow participants to access their data and compare it with de-identified data from all other users and across hospitals where they operate;
 3. allow corrective action in the event of significant adverse patient outcomes; and
 4. provide a collection of de-identified data for training, research and publication, including in presentations at ANZSVS annual conferences, AVA public reports and in local and international publications.
Analysis of data will occur by the Audit Monitoring Committee, comprised of four experienced clinicians elected from the ANZSVS membership.